Safety and Efficacy of Misoprostol versus Oxytocin for the Prevention of Postpartum Hemorrhage
Postpartum hemorrhage (PPH) is the commonest cause of maternal death worldwide. Studies suggest that the use of misoprostol may be beneficial in clinical settings where oxytocin is unavailable. The aim of this study was to compare the safety and efficacy of oxytocin and misoprostol when used in the...
Saved in:
| Main Authors: | Minoo Rajaei, Samieh Karimi, Zohreh Shahboodaghi, Hamidreza Mahboobi, Tahereh Khorgoei, Farzam Rajaei |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2014-01-01
|
| Series: | Journal of Pregnancy |
| Online Access: | http://dx.doi.org/10.1155/2014/713879 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Perceived acceptability of an inhaled oxytocin for the prevention of postpartum haemorrhage in Ethiopia
by: Victoria L Oliver, et al.
Published: (2020-07-01) -
Effect on postpartum hemorrhage of prophylactic oxytocin (10 IU) by injection by community health officers in Ghana: a community-based, cluster-randomized trial.
by: Cynthia K Stanton, et al.
Published: (2013-10-01) -
Misoprostol alone for the termination of pregnancy
by: Martin Cuellar Torriente, et al.
Published: (2007-04-01) -
Misoprostol alone for the termination of pregnancy
by: J. van Eeden
Published: (2007-09-01) -
Carboprost versus Oxytocin as the first-line treatment of primary postpartum haemorrhage (COPE): protocol for a phase IV, double-blind, double-dummy, randomised controlled trial and economic analysis
by: Kerry Woolfall, et al.
Published: (2025-05-01)